Advertising in the Indian Journal of Plastic Surgery: A Complete Guide to IJPS Ad Rates, Formats, and How to Reach India's Top Plastic Surgeons

Most pharmaceutical and medical device brands we speak with have never seriously considered the Indian Journal of Plastic Surgery as a media channel — and that, frankly, is a missed opportunity that surprises us every time. The IJPS reaches a concentrated, high-prescribing audience of plastic surgeons India-wide which no mass media channel can replicate at any price; and when you calculate the cost per qualified impression against what those same brands are spending on conference sponsorships or digital banners, the numbers tell a very different story than most media plans suggest.

Why Advertise in the Indian Journal of Plastic Surgery?

The honest answer is that most brands get this wrong by treating medical journal advertising as a prestige play rather than a performance channel. The Indian Journal of Plastic Surgery is the official publication of the Association of Plastic Surgeons of India — the APSI — which means every institutional subscriber, every personal subscriber, and every digital reader is, by definition, a credentialed professional with direct purchasing influence over surgical consumables, implants, pharmaceuticals, and medical devices. That is a level of audience qualification which no programmatic display campaign can guarantee, regardless of how sophisticated the targeting parameters appear on paper.

The journal has been publishing since 1968, which gives it a depth of institutional trust among plastic surgeons India-wide that newer, flashier platforms simply have not earned yet. When a brand appears in IJPS, it is appearing in the same pages that a reconstructive surgery specialist in Chandigarh or an aesthetic surgery practitioner in Bengaluru turns to for peer-reviewed clinical evidence; and that adjacency carries a credibility premium which is genuinely difficult to quantify but consistently reported by our clients as influencing prescriber confidence. At SmartAds, we always tell our clients that the question is not whether medical journal advertising works — it is whether you are targeting the right journal for your specific audience, and for anything touching plastic surgery, reconstructive surgery, or aesthetic surgery in India, IJPS is the answer.

On top of that, the journal's transition to a diamond open access model — meaning content is freely available to readers without a paywall and without author publication charges — has significantly expanded its digital footprint. Articles published in IJPS are now accessible to a far wider global audience than traditional subscription-gated journals, which means your advertisement, whether print or digital, is being seen not just by APSI members but by surgeons, residents, and medical professionals across South East Asia and beyond who access the journal through open.thieme.com or thieme-connect.com. For international pharmaceutical or device companies looking to enter or strengthen their presence in the Indian plastic surgery market, this open access reach is a genuine strategic advantage.

Who Reads the Indian Journal of Plastic Surgery — And Why It Matters for Advertisers?

The readership profile of IJPS is, in our experience, one of the most precisely defined audiences in Indian medical publishing. The Association of Plastic Surgeons of India has a membership base of approximately 2,000 plastic surgeons India-wide, which forms the core institutional readership; but the actual reach extends considerably further when you account for plastic surgery residents, maxillofacial surgeons, burn specialists, and reconstructive surgery fellows who access the journal through institutional library subscriptions at medical colleges and teaching hospitals.

What a lot of people miss is the subspecialty depth within that audience. IJPS readers are not a monolithic group of "surgeons" — they segment meaningfully into reconstructive surgery specialists who are primary targets for tissue repair products and microsurgical instruments, aesthetic surgery practitioners who are the key audience for dermal fillers, implants, and cosmetic surgery consumables, craniofacial and pediatric plastic surgeons who represent a distinct purchasing cluster for specialized fixation devices, and burn and trauma reconstruction specialists who are highly relevant for advanced wound care products. Any brand running a physician-targeted advertising campaign in this space should be thinking about which subspecialty cluster their product speaks to most directly, because IJPS content is organized in ways that make subspecialty-specific placement genuinely possible.

Our experience at SmartAds shows that key opinion leaders — the senior plastic surgeons who sit on hospital purchase committees and influence formulary decisions at major private hospital chains — are disproportionately represented among IJPS readers. These are the individuals who attend APSI annual conferences, who contribute to the journal's peer review process, and who are actively engaged with the clinical literature in ways that make them receptive to brand messaging that is evidence-adjacent and professionally presented. The target audience here is not just large; it is influential in ways that matter enormously for pharmaceutical advertising and medical device advertising strategy.

What Types of Ads Can You Place in the Indian Journal of Plastic Surgery?

Print advertising in IJPS follows the standard formats that Thieme Medical Publishers applies across its portfolio of medical journals, with a few IJPS-specific placement opportunities that are worth understanding before you brief your creative team. The full-page advertisement is the most commonly booked format and occupies a complete page within the journal's editorial run; the half-page advertisement offers a more cost-efficient entry point for brands that are testing the channel or working within tighter budgets. Beyond standard run-of-journal placements, there are premium positions — the inside front cover, the inside back cover, and the back cover ad — which command higher rates but deliver significantly elevated visibility because they are the positions readers encounter before and after engaging with the editorial content.

Advertorial placement is another option which we have found particularly effective for pharmaceutical advertising campaigns where the brand message benefits from editorial framing. An advertorial in IJPS allows a company to present clinical data, case study summaries, or product education content in a format that sits comfortably within the journal's reading experience; and because the target audience is scientifically literate, a well-crafted advertorial can do more persuasive work than a conventional display advertisement. Promotional inserts — loose or bound — are also available and can be particularly useful for product launch campaigns where a brand wants to distribute a detailed brochure or clinical summary alongside the journal issue.

On the digital side, advertising options through thieme-connect.com include banner placements on the IJPS journal homepage, article-level display advertising which places your brand message adjacent to specific clinical content, and email newsletter promotion through the Quarterly Plastic Surgery E-newsletter — a touchpoint which, in our view, is significantly underutilised by most advertisers. The eFirst publication model, where articles are published online ahead of print, creates an additional digital advertising window; brands can sponsor eFirst article notifications or secure banner adjacency to high-traffic eFirst articles in the weeks before a print issue is released. Cross-promotion across print and online channels through a single booking is something Thieme India actively facilitates, and it is an approach we recommend to clients who want to maximize frequency within the IJPS readership.

What Are the Print and Digital Advertising Specifications for IJPS?

Ad specifications for IJPS print placements follow Thieme Medical Publishers' standard production requirements, which are broadly consistent with international medical journal publishing norms. A full-page advertisement is typically set to a trim size of 210mm × 280mm with a bleed allowance of 3mm on all sides and a safe zone of 5mm from the trim edge — these are the dimensions your design team will need to work to, and submitting artwork outside these specifications is one of the most common reasons for print ad delays that we have seen in medical journal advertising campaigns. Files should be submitted as high-resolution PDFs at a minimum of 300 DPI, with all fonts embedded and colour profiles set to CMYK rather than RGB, since RGB files consistently produce colour shifts in print that can make pharmaceutical advertising materials look unprofessional.

Half-page advertisements are available in both horizontal and vertical orientations; the horizontal half-page typically runs at 210mm × 138mm while the vertical format is approximately 100mm × 280mm, though these dimensions should always be confirmed with Thieme India directly since specifications can vary between issues and any discrepancy between your submitted artwork and the confirmed spec will require a revision round that costs time. For premium positions — the inside front cover and back cover ad specifically — the specifications are identical to full-page but the material submission deadline is typically earlier, because cover positions require press-ready artwork before the main body of the journal goes to print.

For digital advertising on thieme-connect.com, the standard banner formats follow IAB specifications, with leaderboard placements at 728×90 pixels and medium rectangle formats at 300×250 pixels being the most commonly available; these should be submitted as static or animated GIF or HTML5 files, with file size limits that Thieme India will specify in the digital media kit. Email newsletter promotion through the Quarterly Plastic Surgery E-newsletter requires artwork sized for email rendering, which means designing for mobile-first display — a point which is often overlooked when creative teams accustomed to print production are asked to adapt materials for email newsletter promotion. At SmartAds, we coordinate the full specification compliance process on behalf of our clients, which eliminates the back-and-forth that can otherwise delay a campaign by two to three weeks.

How Do You Contact Thieme India to Book a Journal Ad?

The booking process for advertising in the Indian Journal of Plastic Surgery runs through Thieme Medical and Scientific Publishers Pvt. Ltd., which operates from its India office in Noida, Uttar Pradesh. The primary contact point for advertising enquiries is marketing@thieme.in — this is the email address through which media kits, rate cards, and booking confirmations are handled, and it is worth noting that response times from the Thieme India Noida office are generally prompt for serious enquiries that specify the publication, the desired format, and the issue date you are targeting.

The process itself is relatively straightforward once you have the media kit in hand. You submit a booking request specifying the format — full-page advertisement, half-page advertisement, inside front cover, back cover ad, or insert — along with the issue date and any preference for placement within the journal. Thieme India will confirm availability, provide a booking confirmation, and issue an invoice; artwork is then submitted according to the material deadline specified in the booking confirmation, which for print placements is typically four to six weeks before the publication date of the relevant issue. For digital placements on thieme-connect.com or email newsletter promotion through the Quarterly Plastic Surgery E-newsletter, the lead times are shorter — usually two to three weeks — but we recommend building in additional buffer time for regulatory review of pharmaceutical advertising materials, which can add a week or more depending on your internal compliance process.

What we tell our clients at SmartAds is that the real value of working through an experienced media buying agency for IJPS advertising is not just the rate negotiation — it is the institutional knowledge of how Thieme India's booking process works, which deadlines are firm versus flexible, and how to structure a multi-issue booking that maximises both reach and cost efficiency. A brand manager approaching marketing@thieme.in for the first time without a media partner will get a rate card; a brand manager working with SmartAds will get a media plan that integrates IJPS into a broader physician-targeted advertising strategy with clear KPIs and reporting.

IJPS Advertising Rates and Cost Overview

Frankly speaking, the absence of publicly available rate card information for the Indian Journal of Plastic Surgery is one of the most consistent frustrations we hear from brand managers who are trying to build a business case for medical journal advertising before they have even made a first enquiry. So let us be direct about what the market looks like, based on our experience with Thieme India bookings and comparable medical journal advertising across the Indian market.

A full-page advertisement in IJPS works out to somewhere in the ballpark of ₹40,000 to ₹60,000 per issue for a standard run-of-journal placement — a figure which surprises many brand managers when they compare it to what they are spending on a single day of digital banner advertising that reaches a largely unqualified audience. The inside front cover commands a premium of roughly 30 to 50 percent above the standard full-page rate, which puts it in the range of ₹55,000 to ₹90,000 per issue; the back cover ad is typically the highest-priced print position, often working out to somewhere between ₹70,000 and ₹1,00,000 per issue depending on negotiation and booking volume. Half-page advertisement rates are generally in the range of ₹20,000 to ₹35,000 per issue, making them a sensible starting point for brands that are new to IJPS advertising and want to test the channel before committing to a full campaign.

These advertising rates are, to be clear, indicative benchmarks based on our agency's experience with Thieme India bookings and comparable medical journal India pricing; the actual rates you receive will depend on booking volume, issue selection, and whether you are bundling print advertising with digital placements on thieme-connect.com. Multi-issue bookings — across the six issues per year that IJPS publishes as a bi-monthly journal — typically attract discounts of somewhere between 10 and 20 percent, which makes a full-year commitment considerably more cost-efficient than booking individual issues on an ad hoc basis. For international advertisers, rates may be quoted in USD, and the equivalent figures work out to roughly $500 to $1,200 for standard print placements, which compares very favourably to advertising rates in comparable international plastic surgery journals.

Indexing, Impact Factor, and Why Journal Credibility Matters to Advertisers

A peer-reviewed journal's indexing status is not just an academic metric — it is a direct proxy for the quality and engagement of its readership, which makes it one of the most important factors in evaluating a journal as an advertising platform. The Indian Journal of Plastic Surgery carries PubMed indexed journal status, meaning its content is discoverable through the world's most widely used medical literature database; it is also Scopus indexed, which is the standard international benchmark for scientific journal quality, and it is listed in the DOAJ — the Directory of Open Access Journals — which validates its open access credentials. On top of that, IJPS is indexed in the Emerging Sources Citation Index (ESCI), which is part of the Web of Science family, and it maintains CrossRef DOI registration for all published articles.

The impact factor and Cite Score of IJPS are metrics that matter to advertisers for a specific reason — journals with higher citation metrics attract more active researchers and clinicians who are engaged with the current scientific literature, and those are precisely the readers who are making evidence-informed purchasing decisions about pharmaceutical advertising products and medical devices. While the IJPS impact factor and Cite Score have shown positive trajectory in recent years as the journal's open access transition has expanded its international visibility, we recommend checking the most current figures directly through Clarivate or Scopus, since citation metrics are updated annually and any figure we quote here will be superseded. What we can say with confidence is that the journal's indexing breadth — PubMed, Scopus, DOAJ, ESCI — places it firmly in the top tier of plastic surgery journal India publications, which is the credibility context your brand is associating with when you advertise in IJPS.

Journal indexing also matters for regulatory reasons, which we will address in more detail in the compliance section below; but the short version is that advertising in a peer-reviewed journal with full journal indexing credentials provides a defensible, professionally appropriate context for pharmaceutical advertising and medical device advertising that is harder to establish in non-indexed publications. The ICMJE — International Committee of Medical Journal Editors — guidelines, which IJPS adheres to, and the COPE — Committee on Publication Ethics — membership of Thieme Medical Publishers both signal that this is a publication operating to the highest editorial standards, which is the kind of institutional credibility that reflects positively on the brands that appear within its pages.

What Are the Ethical and Regulatory Guidelines for Advertising in Indian Medical Journals?

This is the section that most brand managers skip and then wish they had read. Advertising in Indian medical journals is not the same as advertising in consumer publications — it is governed by a specific and increasingly enforced regulatory framework which, if not followed correctly, can expose a brand to significant legal and reputational risk. The Drugs and Cosmetics Act, 1940 is the foundational legislation, and it prohibits claims in pharmaceutical advertising that are not supported by the approved prescribing information; any advertisement for a scheduled drug appearing in IJPS must be consistent with the product's approved label and must not make claims that go beyond what the regulatory dossier supports.

The UCPMP — Uniform Code for Pharmaceutical Marketing Practices — issued by the Department of Pharmaceuticals is the industry-specific code which governs how pharmaceutical companies may promote their products to healthcare professionals, including through journal advertising. The UCPMP requires that pharmaceutical advertising directed at physicians must be accurate, balanced, and not misleading; it prohibits the use of gifts, inducements, or promotional claims that are not evidence-based; and it mandates that all promotional materials be reviewed and approved through the company's internal medical affairs process before publication. For medical device advertisers, the parallel framework is the UCMPMD — Uniform Code for Marketing Practices in Medical Devices — which applies similar standards to surgical equipment advertising and device promotion. Thieme Medical Publishers, as the publisher of IJPS, has its own advertising acceptance policy which is aligned with these codes; and advertisements that do not meet the editorial and regulatory standards of the journal will not be accepted, regardless of the booking value.

What we have seen backfire, in our experience managing pharmaceutical advertising campaigns, is brands submitting artwork that has been approved for international markets without adapting it for Indian regulatory requirements. The UCPMP and UCMPMD have specific requirements around the presentation of clinical data, the inclusion of prescribing information summaries, and the use of comparative claims which differ from FDA or EMA standards; and a creative execution that is perfectly compliant in Europe may require significant revision before it can be placed in a PubMed indexed journal in India. At SmartAds, we build regulatory review time into every medical journal advertising campaign timeline, and we work with our clients' medical affairs teams to ensure that ad specifications and content are compliant before artwork is submitted to marketing@thieme.in.

What Is the Return on Investment for Medical Journal Advertising in India?

The ROI conversation around medical journal advertising is one that we have had hundreds of times, and the honest answer is that it depends entirely on how you are measuring it — which is a more nuanced position than most media planning conversations allow for. If you are measuring ROI purely on cost-per-impression, journal advertising will always look expensive compared to digital channels; a bi-monthly journal with a circulation of a few thousand copies cannot compete with a digital campaign delivering millions of impressions. But if you are measuring ROI on cost-per-qualified-physician-impression — the number of times your brand message reaches a credentialed specialist who has direct prescribing or purchasing authority over your product category — the calculation changes dramatically.

To put some numbers around it: if IJPS reaches somewhere in the region of 2,000 to 3,000 active plastic surgeons India-wide through print and institutional subscriptions, plus a significantly larger digital audience through open access on thieme-connect.com, the cost per qualified physician impression for a full-page advertisement works out to somewhere between ₹15 and ₹30 per surgeon — a figure which, when you consider the lifetime prescribing value of a single converted plastic surgeon for a pharmaceutical or device brand, represents genuinely compelling economics. One medical device client we worked with — a company launching a new tissue expander product in the Indian market — ran a three-issue campaign in IJPS alongside a conference sponsorship at the APSI annual meeting; the journal campaign was credited by their sales team with generating brand recognition among surgeons in Tier 2 cities who had not attended the conference, which would have been essentially unreachable through any other targeted channel at a comparable cost.

The ROI of medical journal advertising is also partly a frequency and consistency story. A single insertion in IJPS will generate awareness; a sustained six-issue campaign — which, for a bi-monthly journal, means a full year of presence — builds the kind of brand familiarity that influences prescribing behaviour over time. The GroupM TYNY Report and Dentsu e4m Report both consistently highlight the resilience of specialist print advertising in India's healthcare sector, where physician-targeted advertising through peer-reviewed publications continues to deliver measurable brand recall metrics that outperform digital-only campaigns for the same target audience. What we tell our clients is that the optimal approach is a cross-promotion print and online strategy — print advertising in the journal for authority and recall, digital advertising on thieme-connect.com for frequency and click-through — which delivers the full-funnel impact that neither channel achieves alone.

How Does IJPS Compare to Other Medical Journals for Advertising in India?

The Indian medical journal advertising landscape is more crowded than most brand managers realise, and choosing the right publication — or the right combination of publications — requires a clear understanding of how audience profiles differ across journals. The Indian Journal of Plastic Surgery is the only dedicated plastic surgery journal India publishes with full APSI institutional backing, which gives it a specificity advantage over broader surgical journals like the Indian Journal of Surgery or the Journal of Minimal Access Surgery. Those journals reach a wider surgical audience, which can be an advantage for brands with broad surgical applications; but for products specifically targeting plastic surgeons India-wide, the audience dilution in a general surgery journal means you are paying for a significant proportion of impressions that will never convert.

The Journal of Minimal Access Surgery, for example, has a strong readership among laparoscopic and endoscopic surgeons — a very different prescribing profile from the reconstructive surgery and aesthetic surgery specialists who form the IJPS core audience. If your product is a suture material or a general anaesthetic agent with broad surgical applications, a multi-journal strategy that includes both IJPS and a general surgery publication makes sense; if your product is a breast implant, a fat grafting cannula, or a topical scar treatment, IJPS is the primary vehicle and the others are secondary at best. We have seen brands waste significant portions of their medical journal advertising budget by defaulting to the journals with the highest overall circulation rather than the journals with the most relevant specialist readership.

For international advertisers — particularly companies based in the US, Europe, or Japan that are targeting the Indian plastic surgery market — IJPS offers something that international plastic surgery journals cannot: direct, cost-efficient access to the Indian and South East Asia plastic surgery journal readership at Indian market rates. Advertising in a US-based plastic surgery journal to reach Indian surgeons is an indirect and expensive approach; advertising in IJPS reaches the same surgeons in the publication they read most regularly, in the professional context they trust most, at a fraction of the cost. The open access model also means that IJPS content — and the advertising that appears alongside it — is now reaching an international audience of researchers and clinicians who access the journal through open.thieme.com, which adds a layer of international brand visibility that was not available when the journal operated on a subscription-only model.

Which Advertisers Benefit Most from the IJPS Platform?

To be honest, the question of who should advertise in IJPS is easier to answer by exclusion than by inclusion. This is not a channel for consumer brands, for general healthcare products, or for pharmaceutical companies whose primary target is general practitioners — those advertisers have better options in consumer health publications or broader medical journals. The brands that get the most from IJPS advertising are those whose products have a direct, specific application in plastic surgery, reconstructive surgery, aesthetic surgery, or cosmetic surgery practice.

Pharmaceutical advertising in IJPS is most effective for companies marketing products used perioperatively — local anaesthetics, antibiotics with surgical prophylaxis indications, analgesics used in post-surgical pain management, and topical agents for wound healing and scar management. Medical device advertising is arguably even better suited to the IJPS platform; surgical equipment advertising for instruments, implants, tissue expanders, microsurgical tools, and imaging systems used in plastic surgery reaches its most qualified audience through this channel. A surgical equipment advertising campaign we managed for a European device manufacturer entering the Indian market — running a combination of full-page advertisement placements in IJPS and banner advertising on thieme-connect.com — generated distributor enquiries from six cities within the first quarter, which the client attributed directly to the brand recognition built through the journal campaign.

Institutional advertisers — medical colleges with plastic surgery training programmes, hospital groups looking to recruit plastic surgeons, and continuing medical education providers — also find IJPS a highly effective platform for reaching the APSI members advertising reach. The journal's institutional subscription base at teaching hospitals and medical universities means that a significant proportion of readers are senior faculty and department heads who are decision-makers for both clinical and institutional purchasing. On top of that, companies offering institutional subscription packages, medical library services, or professional development resources find a highly receptive audience among IJPS readers, which is a segment of the advertiser market that is almost entirely absent from the journal's current advertising mix — representing a genuine opportunity for brands willing to think creatively about the platform.

Frequently Asked Questions About Advertising in the Indian Journal of Plastic Surgery

Q: How do I advertise in the Indian Journal of Plastic Surgery?

The process begins with a direct enquiry to Thieme Medical and Scientific Publishers Pvt. Ltd. through their India office, with the primary contact being marketing@thieme.in. You should specify the format you are interested in — full-page advertisement, half-page advertisement, inside front cover, back cover ad, or insert — along with the issue date you are targeting and any preference for placement within the journal. Thieme India will respond with a media kit, rate card, and availability confirmation; once you confirm the booking, artwork is submitted according to the material deadline specified, which is typically four to six weeks before the publication date for print placements. Working through a media buying agency like SmartAds.in simplifies this process considerably, particularly for multi-issue bookings or campaigns that combine print advertising with digital placements on thieme-connect.com.

Q: What are the advertising rates for the Indian Journal of Plastic Surgery?

Thieme India does not publish a publicly available rate card for IJPS advertising, which is why most brand managers struggle to build a budget estimate before making a first enquiry. Based on our experience with Thieme India bookings, standard print advertising rates work out to somewhere in the range of ₹40,000 to ₹60,000 for a full-page advertisement, ₹20,000 to ₹35,000 for a half-page advertisement, and ₹70,000 to ₹1,00,000 for premium positions like the back cover ad and inside front cover. Multi-issue bookings across the six issues per year that IJPS publishes typically attract discounts of 10 to 20 percent. Digital advertising rates on thieme-connect.com are quoted separately and depend on the format and duration of the placement.

Q: Who is the target audience of the Indian Journal of Plastic Surgery?

The primary target audience is the membership of the Association of Plastic Surgeons of India, which comprises approximately 2,000 plastic surgeons India-wide; but the actual readership extends to plastic surgery residents, reconstructive surgery fellows, maxillofacial surgeons, burn specialists, and aesthetic surgery practitioners who access the journal through institutional subscriptions at teaching hospitals and medical colleges. The IJPS readership also includes an international component — researchers and clinicians across South East Asia and globally who access the journal through its open access platform on open.thieme.com. For advertisers, the most commercially significant segment is the senior plastic surgeon cohort, which includes key opinion leaders who sit on hospital purchase committees and influence formulary and procurement decisions.

Q: How many issues does IJPS publish per year and what are the booking deadlines?

The Indian Journal of Plastic Surgery is a bi-monthly journal, publishing six issues per year — typically in February, April, June, August, October, and December, though the exact schedule should be confirmed with Thieme India at the time of booking. Material deadlines for print advertising are generally four to six weeks before the publication date of each issue, which means that for a February issue, artwork would typically need to be submitted by late December or early January. For premium positions — the inside front cover and back cover ad — the deadline is often earlier than for run-of-journal placements, so it is important to confirm the specific deadline for your chosen position at the time of booking. The eFirst publication model also creates digital advertising windows ahead of each print issue, with shorter lead times of two to three weeks.

Q: What ad formats are available in the Indian Journal of Plastic Surgery?

The available formats include full-page advertisement, half-page advertisement (in horizontal or vertical orientation), quarter-page advertisement, inside front cover, inside back cover, back cover ad, and promotional inserts — both loose and bound. On the digital side, banner advertising on thieme-connect.com is available in standard IAB formats, and email newsletter promotion through the Quarterly Plastic Surgery E-newsletter is an additional touchpoint. Advertorial placement — editorial-style promotional content — is available subject to Thieme India's editorial guidelines and must be clearly labelled as promotional content in accordance with ICMJE standards and UCPMP requirements.

Q: Is the Indian Journal of Plastic Surgery indexed in PubMed and Scopus?

Yes — IJPS carries PubMed indexed journal status and is also Scopus indexed, which places it among the most credentialed plastic surgery journal India publications. On top of that, it is listed in the DOAJ and indexed in the Emerging Sources Citation Index (ESCI), with CrossRef DOI registration for all published articles. This breadth of journal indexing is significant for advertisers because it signals the quality and engagement level of the readership — a PubMed indexed journal attracts active clinical researchers and evidence-informed practitioners who are precisely the audience that pharmaceutical advertising and medical device advertising campaigns need to reach.

Q: What is the impact factor and Cite Score of IJPS?

The impact factor and Cite Score of IJPS have shown positive momentum as the journal's open access transition has expanded its international citation reach. We recommend checking the most current figures directly through Clarivate's Journal Citation Reports for the impact factor and through Elsevier's Scopus database for the Cite Score, since both metrics are updated annually and any specific figure cited here would quickly become outdated. What is relevant for advertisers is the directional trend — a journal with improving citation metrics is attracting more engaged, research-active readers, which is the demographic profile most valuable for physician-targeted advertising campaigns.

Q: How many plastic surgeons in India read the Indian Journal of Plastic Surgery?

The APSI membership of approximately 2,000 plastic surgeons India-wide forms the core readership, with additional reach through institutional subscriptions at medical colleges, teaching hospitals, and postgraduate training programmes. The open access transition has expanded the digital readership significantly beyond this base — articles published on open.thieme.com are accessible to any surgeon or researcher globally without a subscription, which means the total digital audience is considerably larger than the print circulation. For advertising purposes, the print and institutional subscription audience of roughly 2,000 to 3,000 qualified plastic surgery professionals represents the highest-value impression pool, while the digital audience provides additional frequency and international reach.

Q: Can international pharmaceutical or device companies advertise in IJPS?

Yes — Thieme Medical Publishers actively accommodates international advertisers, and the process through marketing@thieme.in is the same regardless of whether the booking company is based in India or internationally. Rates for international advertisers may be quoted in USD, and the figures work out to roughly $500 to $1,200 for standard print placements, which compares very favourably to advertising rates in comparable international plastic surgery journals. International companies should be aware that advertisements placed in IJPS — even if the company is headquartered abroad — must comply with Indian regulatory requirements including the UCPMP and UCMPMD if the product is marketed or distributed in India, since the readership is primarily Indian-based plastic surgeons.

Q: What are the ethical and regulatory requirements for advertising in Indian medical journals?

The key regulatory frameworks are the Drugs and Cosmetics Act, 1940, the UCPMP — Uniform Code for Pharmaceutical Marketing Practices — issued by the Department of Pharmaceuticals, and the UCMPMD for medical device advertisers. All pharmaceutical advertising in IJPS must be consistent with the approved prescribing information for the product, must not make unsubstantiated claims, and must be reviewed and approved through the company's internal medical affairs process before submission. Thieme Medical Publishers has its own advertising acceptance policy aligned with ICMJE guidelines and COPE standards, which means non-compliant advertisements will not be accepted regardless of booking status. Building regulatory review time into your campaign timeline — typically two to four weeks for pharmaceutical advertising materials — is essential to avoid missing material deadlines.

Q: What is the ROI of advertising in a peer-reviewed medical journal in India?

The ROI of medical journal advertising is most meaningfully measured on cost-per-qualified-physician-impression rather than raw cost-per-impression. For IJPS, the cost per qualified plastic surgeon impression works out to somewhere between ₹15 and ₹30 for a standard print placement — a figure that represents strong value when compared to the cost of reaching the same surgeon through conference sponsorship, medical representative visits, or digital advertising with imprecise targeting. The ROI medical journal ads deliver is also a cumulative frequency story; a sustained presence across multiple issues of a bi-monthly journal builds brand familiarity among key opinion leaders in ways that single-touchpoint campaigns cannot replicate.

Q: Does the Indian Journal of Plastic Surgery offer digital or online advertising options?

Yes — digital advertising is available through thieme-connect.com, where banner placements adjacent to IJPS content can be booked in standard IAB formats. The Quarterly Plastic Surgery E-newsletter represents an additional email newsletter promotion channel which reaches IJPS subscribers directly in their inboxes. The eFirst publication model creates digital advertising opportunities ahead of each print issue, and the open access platform on open.thieme.com generates organic digital traffic to IJPS content from an international audience. A cross-promotion print and online strategy — combining print advertising in the journal with digital placements on thieme-connect.com — is the approach we recommend for brands that want to maximise both reach and frequency within the IJPS audience.

Q: How do I contact Thieme India to book an advertisement in IJPS?

The primary contact for IJPS advertising bookings is marketing@thieme.in, which is managed by Thieme Medical and Scientific Publishers Pvt. Ltd. at their Thieme India Noida office in Uttar Pradesh. Initial enquiries should specify the publication (Indian Journal of Plastic Surgery), the desired format, the target issue date, and the company's product category, which allows the Thieme India team to respond with relevant rate information and availability. For brands that prefer to work through a media buying agency, SmartAds.in manages the full booking process on behalf of clients, including rate negotiation, artwork coordination, and regulatory compliance review.

Q: What is the difference between print advertising and eFirst/digital promotion in IJPS?

Print advertising in IJPS appears in the physical journal issue and in the PDF version of that issue distributed to